Jeffrey N. Simmons - 17 Oct 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: PRESIDENT, CEO AND DIRECTOR, Director
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol: ELAN
Transactions as of: 17 Oct 2025
Net transactions value: +$2,769
Form type: 4
Filing time: 21 Oct 2025, 16:21:52 UTC
Previous filing: 07 Oct 2025
Next filing: 04 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR, Director	C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	21 Oct 2025	0001479079

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Deferred Stock Units	Award	$2,769	+129	+0.72%	$21.42	18,100	17 Oct 2025	Common Stock	129		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2	Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.